Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022387619> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W3022387619 abstract "Abstract Introduction Metformin is the first-line drug for treatment of Type 2 diabetes. A meta-analysis of 70,490 patient-years of metformin use reported no lactic acidosis. We present a case of a patient who developed lactic acidosis while on Metformin; with other contributing factors. Case Description A 72-year old male with dementia, diabetes, hypertension, hypothyroidism and “muscular dystrophy” was admitted with encephalopathy. Medications included levothyroxine, donepezil, insulin glargine and metformin. A Brain CT scan revealed frontal lobe atrophy and lacunar infarcts. Admission blood work revealed lactic acidosis of 5.6. Sepsis workup was negative. Metformin was discontinued, and the patient improved with intravenous hydration. Upon discharge, Metformin was restarted. Follow-up lactic acid was normal. After a subsequent hospitalization with similar presentation and peak lactic acid of 4.7, metformin was stopped altogether. The patient was referred to a neuromuscular specialist and a diagnosis of Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) was made. The “muscular dystrophy” was likely mitochondrial disease. A third hospitalization (while not on Metformin) saw a peak lactic acid of 2.8. We concluded that the lactic acidosis was secondary to MELAS, but Metformin had caused the significant spikes seen during the first two hospitalizations. Discussion Mitochondrial disorders must be in the differential diagnosis for patients diagnosed with muscular dystrophy. The hallmark of MELAS syndrome is stroke-like episodes that result in hemiparesis, hemianopia, or cortical blindness. Other features include seizures, recurrent headaches, vomiting, short stature, and muscle weakness. Patients with mitochondrial diseases also have a high incidence of diabetes. Lactic acidosis occurs during stress. DNA testing is the gold standard for diagnosis. Conclusion Metformin is contraindicated in patients with mitochondrial disease and diabetes due to the predisposition for lactic acidosis. This is not part of the current package inserts for prescribers and patients- and we strongly recommend inclusion of this language." @default.
- W3022387619 created "2020-05-13" @default.
- W3022387619 creator A5017117201 @default.
- W3022387619 creator A5058960550 @default.
- W3022387619 date "2020-04-01" @default.
- W3022387619 modified "2023-10-16" @default.
- W3022387619 title "SUN-683 Was Metformin the Culprit for This Lactic Acidosis?" @default.
- W3022387619 doi "https://doi.org/10.1210/jendso/bvaa046.1516" @default.
- W3022387619 hasPublicationYear "2020" @default.
- W3022387619 type Work @default.
- W3022387619 sameAs 3022387619 @default.
- W3022387619 citedByCount "0" @default.
- W3022387619 crossrefType "journal-article" @default.
- W3022387619 hasAuthorship W3022387619A5017117201 @default.
- W3022387619 hasAuthorship W3022387619A5058960550 @default.
- W3022387619 hasBestOaLocation W30223876191 @default.
- W3022387619 hasConcept C104317684 @default.
- W3022387619 hasConcept C118552586 @default.
- W3022387619 hasConcept C126322002 @default.
- W3022387619 hasConcept C134018914 @default.
- W3022387619 hasConcept C185592680 @default.
- W3022387619 hasConcept C24586158 @default.
- W3022387619 hasConcept C2775833069 @default.
- W3022387619 hasConcept C2777172819 @default.
- W3022387619 hasConcept C2777180221 @default.
- W3022387619 hasConcept C2778186239 @default.
- W3022387619 hasConcept C2779799828 @default.
- W3022387619 hasConcept C2780317664 @default.
- W3022387619 hasConcept C2780323712 @default.
- W3022387619 hasConcept C55493867 @default.
- W3022387619 hasConcept C555293320 @default.
- W3022387619 hasConcept C71924100 @default.
- W3022387619 hasConceptScore W3022387619C104317684 @default.
- W3022387619 hasConceptScore W3022387619C118552586 @default.
- W3022387619 hasConceptScore W3022387619C126322002 @default.
- W3022387619 hasConceptScore W3022387619C134018914 @default.
- W3022387619 hasConceptScore W3022387619C185592680 @default.
- W3022387619 hasConceptScore W3022387619C24586158 @default.
- W3022387619 hasConceptScore W3022387619C2775833069 @default.
- W3022387619 hasConceptScore W3022387619C2777172819 @default.
- W3022387619 hasConceptScore W3022387619C2777180221 @default.
- W3022387619 hasConceptScore W3022387619C2778186239 @default.
- W3022387619 hasConceptScore W3022387619C2779799828 @default.
- W3022387619 hasConceptScore W3022387619C2780317664 @default.
- W3022387619 hasConceptScore W3022387619C2780323712 @default.
- W3022387619 hasConceptScore W3022387619C55493867 @default.
- W3022387619 hasConceptScore W3022387619C555293320 @default.
- W3022387619 hasConceptScore W3022387619C71924100 @default.
- W3022387619 hasLocation W30223876191 @default.
- W3022387619 hasLocation W30223876192 @default.
- W3022387619 hasOpenAccess W3022387619 @default.
- W3022387619 hasPrimaryLocation W30223876191 @default.
- W3022387619 hasRelatedWork W10195258 @default.
- W3022387619 hasRelatedWork W12318411 @default.
- W3022387619 hasRelatedWork W17819937 @default.
- W3022387619 hasRelatedWork W18686838 @default.
- W3022387619 hasRelatedWork W19707534 @default.
- W3022387619 hasRelatedWork W20749215 @default.
- W3022387619 hasRelatedWork W3076778 @default.
- W3022387619 hasRelatedWork W3209158 @default.
- W3022387619 hasRelatedWork W6387984 @default.
- W3022387619 hasRelatedWork W515338 @default.
- W3022387619 isParatext "false" @default.
- W3022387619 isRetracted "false" @default.
- W3022387619 magId "3022387619" @default.
- W3022387619 workType "article" @default.